These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 11211372

  • 21. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
    Spencer TJ, Abikoff HB, Connor DF, Biederman J, Pliszka SR, Boellner S, Read SC, Pratt R.
    Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
    [Abstract] [Full Text] [Related]

  • 22. Methylphenidate dosing: twice daily versus three times daily.
    Stein MA, Blondis TA, Schnitzler ER, O'Brien T, Fishkin J, Blackwell B, Szumowski E, Roizen NJ.
    Pediatrics; 1996 Oct; 98(4 Pt 1):748-56. PubMed ID: 8885956
    [Abstract] [Full Text] [Related]

  • 23. A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study.
    Biederman J, Swanson JM, Wigal SB, Boellner SW, Earl CQ, Lopez FA, Modafinil ADHD Study Group.
    J Clin Psychiatry; 2006 May; 67(5):727-35. PubMed ID: 16841622
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A, Richard C, Prinzo R, Binder C.
    Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Acute effects of methylphenidate on performance during the Test of Variables of Attention in children with attention deficit/hyperactivity disorder.
    Huang YS, Chao CC, Wu YY, Chen YY, Chen CK.
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):219-25. PubMed ID: 17472588
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL.
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [Abstract] [Full Text] [Related]

  • 31. Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial.
    Akhondzadeh S, Tavakolian R, Davari-Ashtiani R, Arabgol F, Amini H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):841-5. PubMed ID: 12921918
    [Abstract] [Full Text] [Related]

  • 32. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
    Biederman J, Wigal SB, Spencer TJ, McGough JJ, Mays DA.
    Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Modafinil in children with attention-deficit hyperactivity disorder.
    Rugino TA, Samsock TC.
    Pediatr Neurol; 2003 Aug; 29(2):136-42. PubMed ID: 14580657
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults.
    Taylor FB, Russo J.
    J Child Adolesc Psychopharmacol; 2000 Aug; 10(4):311-20. PubMed ID: 11191692
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effectiveness of methylphenidate in Native American children with fetal alcohol syndrome and attention deficit/hyperactivity disorder: a controlled pilot study.
    Oesterheld JR, Kofoed L, Tervo R, Fogas B, Wilson A, Fiechtner H.
    J Child Adolesc Psychopharmacol; 1998 Aug; 8(1):39-48. PubMed ID: 9639078
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysis.
    Wang SM, Han C, Lee SJ, Jun TY, Patkar AA, Masand PS, Pae CU.
    J Psychiatr Res; 2017 Jan; 84():292-300. PubMed ID: 27810669
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.